National Cinemedia Inc. Stock
€0.31
Your prediction
Financial data and news for National
sharewise wants to provide you with the best news and tools for National, so we directly link to the best financial data sources.
Financials
News
MarketBeat Week in Review – 06/22 - 06/26
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- SpaceX IPO excitement faded quickly as AI sector volatility increased, and reports suggested OpenAI could delay its IPO until
PowerFleet Q4 Earnings Call Highlights
Key Points
- Interested in PowerFleet, Inc.? Here are five stocks we like better.
- PowerFleet said fiscal 2026 was a turning point, with revenue up 22% to $443.8 million and services making up
Motorpoint Group H2 Earnings Call Highlights
Key Points
- Interested in Motorpoint Group Plc? Here are five stocks we like better.
- Motorpoint posted record FY2026 performance, selling just under 65,000 retail units as profit before tax
Arrow Financial Highlights Profit Gains, Adirondack Bank Deal at Annual Meeting
Key Points
- Interested in Arrow Financial Corporation? Here are five stocks we like better.
- Arrow Financial said 2025 was a transformational year, with stronger profitability, a return to
Planet Labs PBC Q1 Earnings Call Highlights
Key Points
- Interested in Planet Labs PBC? Here are five stocks we like better.
- Planet Labs posted record Q1 revenue of $94 million, up about 42% year over year, and raised its full-year fiscal
Mitie Group H2 Earnings Call Highlights
Key Points
- Interested in Mitie Group plc? Here are five stocks we like better.
- Mitie posted another strong year, with revenue up 10.5% to GBP 5.6 billion and operating profit up 12.8% to GBP
Five Below Q1 Earnings Call Highlights
Key Points
- Interested in Five Below, Inc.? Here are five stocks we like better.
- Five Below crushed Q1 expectations, with net sales up nearly 33% to $1.3 billion and adjusted EPS jumping 158%
B&M European Value Retail H2 Earnings Call Highlights
Key Points
- Interested in B&M European Value Retail S.A.? Here are five stocks we like better.
- B&M posted a tougher fiscal 2026 with lower profits and margin pressure from pricing investment
Edap Tms Unveils FocalTherics Pivot, Targets 40% Growth on HIFU Expansion
Key Points
- Interested in Edap Tms S.A.? Here are five stocks we like better.
- Edap Tms is rebranding as FocalTherics and shifting to a pure-play robotic focal therapy company, with management
Laurentian Bank of Canada Q2 Earnings Call Highlights
Key Points
- Interested in Laurentian Bank of Canada? Here are five stocks we like better.
- Laurentian Bank reported a second-quarter net loss on a reported basis, hit by transaction-related
Hollywood Bowl Group H1 Earnings Call Highlights
Key Points
- Interested in Hollywood Bowl Group plc? Here are five stocks we like better.
- Hollywood Bowl posted record first-half results, with revenue up 9.5% to £141.5 million and adjusted
Is Co-Diagnostics National Security’s Next Diagnostic Pick?
Key Points
- Interested in Co-Diagnostics, Inc.? Here are five stocks we like better.
- The WHO's May 2026 Ebola PHEIC declaration drove immediate gains in biodefense equities, including a 9.7% rise
National Bank of Canada Q2 Earnings Call Highlights
Key Points
- Interested in National Bank of Canada? Here are five stocks we like better.
- National Bank of Canada posted stronger Q2 adjusted results, with EPS up 13% year over year to CAD 3.23
Dycom Industries Q1 Earnings Call Highlights
Key Points
- Interested in Dycom Industries, Inc.? Here are five stocks we like better.
- Dycom delivered a strong fiscal Q1, with revenue up 56% year over year to $1.965 billion and adjusted
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter
Key Points
- Interested in Adherex Technologies Inc.? Here are five stocks we like better.
- Fennec Pharmaceuticals said PEDMARK is seeing stronger commercial traction, with first-quarter 2026
Topps Tiles H1 Earnings Call Highlights
Topps Tiles (LON:TPT) reported broadly flat first-half revenue on a pro forma basis but said stronger gross margins and cost-saving initiatives supported a rise in operating profit, as the tile
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins
Key Points
- Interested in Compass Pathways PLC Sponsored ADR? Here are five stocks we like better.
- Compass Pathways said it remains on track to file a New Drug Application for COMP360 in Q4
Sagicor Financial Q1 Earnings Call Highlights
Sagicor Financial (TSE:SFC) reported softer first-quarter 2026 core earnings as adverse mortality experience in North America and market-related losses weighed on results, though management said it
Pollard Banknote Q1 Earnings Call Highlights
Pollard Banknote (TSE:PBL) reported lower first-quarter revenue and profit, with management attributing the decline primarily to temporary timing and mix issues in its instant ticket business
i-80 Gold Q1 Earnings Call Highlights
i-80 Gold (TSE:IAU) said its first quarter of 2026 marked a turning point for the Nevada-focused gold developer, with management highlighting a completed recapitalization, stronger production from
York Space Systems Q1 Earnings Call Highlights
York Space Systems (NYSE:YSS) reported first-quarter 2026 revenue ahead of internal expectations and reaffirmed its full-year outlook, while management highlighted new commercial and government
Cimpress Touts AI Tailwind, Elevated Products as It Reaffirms 2026 Growth Outlook
Cimpress (NASDAQ:CMPR) told investors at Needham Research’s 21st TMT Consumer Conference that it expects continued growth from its
National Grid Transco H2 Earnings Call Highlights
National Grid Transco (NYSE:NGG) said it delivered stronger full-year earnings and laid out a five-year investment plan centered on grid expansion, demand growth from data centers and
Rank One Computing Q1 Earnings Call Highlights
Rank One Computing (NASDAQ:ROC) reported lower first-quarter revenue in its first earnings call as a public company, as growth in newer
Adherex Technologies Q1 Earnings Call Highlights
Adherex Technologies (NASDAQ:FENC) executives said Fennec Pharmaceuticals entered 2026 with stronger commercial momentum for PEDMARK, reporting higher first-quarter sales, positive operating cash

